£90 MILLION of funding has been channelled into the development of a new cancer drug; known as a POLQ inhibitor, it specifically targets cancer cells with the mutated BRCA genes, while leaving healthy cells unharmed.
You Can See More: Cancer treatment: 'Exciting' new drug targets tumours created by faulty BRCA genes
The following article Cancer treatment: 'Exciting' new drug targets tumours created by faulty BRCA genes is courtesy of Daily Express :: Health Feed
£90 MILLION of funding has been channelled into the development of a new cancer drug; known as a POLQ inhibitor, it specifically targets cancer cells with the mutated BRCA genes, while leaving healthy cells unharmed.
£90 MILLION of funding has been channelled into the development of a new cancer drug; known as a POLQ inhibitor, it specifically targets cancer cells with the mutated BRCA genes, while leaving healthy cells unharmed.
Related Posts:
You Can See More: Monkeypox warning: Five common symptoms of deadly infection - virus in UK for first time- You Can See More: Cancer warning - why you should never ignore this symptom on your groin
- You Can See More: Stomach bloating: Cut this staple food from your diet to prevent tummy pain
- You Can See More: Skin cancer warning: How to tell if your mole is cancerous - Dr Chris reveals
- You Can See More: Hay fever: Could symptoms of the pollen allergy mean you are allergic to your house?
0 comments:
Post a Comment
Note: Only a member of this blog may post a comment.